UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long covid—mechanisms, risk factors, and management

BMJ (Online), 2021-07, p.n1648

2021

Volltextzugriff (PDF)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Molecular psychiatry, 2023-01, Vol.28 (1), p.217-229

2023

Volltextzugriff (PDF)

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease

Ageing research reviews, 2023-08, Vol.89, p.101979-101979, Article 101979

2023

Volltextzugriff (PDF)

Hippocampus‐associated tract degradation follows differential DTI patterns and is influenced by amyloid in MCI patients

Alzheimer's & dementia, 2023-12, Vol.19 (S16), p.n/a

2023

Volltextzugriff (PDF)

Type 2 diabetes mellitus and obesity impact AD‐related pathology through overlapping and independent pathways

Alzheimer's & dementia, 2022-12, Vol.18 (S6), p.n/a

2022

Volltextzugriff (PDF)

Relationships between cerebral tau and glucose metabolism in cognitively normal older adults

Alzheimer's & dementia, 2023-06, Vol.19 (S3), p.n/a

2023

Volltextzugriff (PDF)

Increased pro‐inflammatory plasma markers are associated with a longitudinal decrease in left hippocampal volumes in MCI patients

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Longitudinal evolution of neuropathological substrates of Alzheimer’s disease in obese patients

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Does glucose metabolism dissociate from tau deposition in Alzheimer’s disease?

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Regional neuronal compensation in early and late stages of the Alzheimer’s trajectory

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?

Journal of Alzheimer's disease, 2024, Vol.101 (3), p.987-999

2024

Volltextzugriff (PDF)

Longitudinal FDG‐PET and FTP‐PET demonstrates the relationship between glucose metabolism and tau accumulation in Alzheimer’s disease atrophy‐associated brain regions in cognitively normal older adults

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

2021

Volltextzugriff (PDF)

Cortical diffusivity associates with early neuronal damage

Alzheimer's & dementia, 2022-12, Vol.18 (S5), p.n/a

2022

Volltextzugriff (PDF)

Evaluating the relationship between soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and pathological substrates of Alzheimer’s disease (AD)

Alzheimer's & dementia, 2021-12, Vol.17 (S5), p.n/a

2021

Volltextzugriff (PDF)

Influence of amyloid deposition on the interaction between tau and glucose metabolism

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

2021

Volltextzugriff (PDF)

Does [18F]FDG and [18F]AV1451 PET predict neurodegeneration?

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

2021

Volltextzugriff (PDF)

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

Molecular psychiatry, 2022-04, Vol.27 (4), p.2019-2029

2022

Volltextzugriff (PDF)

Dysfunctional cerebral glucose transport in Alzheimer’s Disease

Alzheimer's & dementia, 2023-12, Vol.19 (S16), p.n/a

2023

Volltextzugriff (PDF)

Evaluation of liraglutide in the treatment of Alzheimer's disease

Alzheimer's & dementia, 2021-12, Vol.17 (S9), p.n/a

2021

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(58)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long covid—mechanisms, risk factors, and management

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease

Hippocampus‐associated tract degradation follows differential DTI patterns and is influenced by amyloid in MCI patients

Type 2 diabetes mellitus and obesity impact AD‐related pathology through overlapping and independent pathways

Relationships between cerebral tau and glucose metabolism in cognitively normal older adults

Increased pro‐inflammatory plasma markers are associated with a longitudinal decrease in left hippocampal volumes in MCI patients

Longitudinal evolution of neuropathological substrates of Alzheimer’s disease in obese patients

Does glucose metabolism dissociate from tau deposition in Alzheimer’s disease?

Regional neuronal compensation in early and late stages of the Alzheimer’s trajectory

Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?

Longitudinal FDG‐PET and FTP‐PET demonstrates the relationship between glucose metabolism and tau accumulation in Alzheimer’s disease atrophy‐associated brain regions in cognitively normal older adults

Cortical diffusivity associates with early neuronal damage

Evaluating the relationship between soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and pathological substrates of Alzheimer’s disease (AD)

Influence of amyloid deposition on the interaction between tau and glucose metabolism

Does [18F]FDG and [18F]AV1451 PET predict neurodegeneration?

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

Dysfunctional cerebral glucose transport in Alzheimer’s Disease

MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASE

Magnetic Resonance Spectroscopy metabolites as biomarkers of Alzheimer’s Disease

Evaluation of liraglutide in the treatment of Alzheimer's disease

Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease

Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease: Neuroimaging / multi‐modal comparisons

Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects

Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects: Neuroimaging / multi‐modal comparisons

Suchergebnisse filtern